OPTI

Optibiotix Health PLC

Health Care First-pass screen £5.06m

370/1000 Overall fit

AI beneficiary 35% 30

Operating leverage 25% 45

Valuation 25% 30

Downside protection 15% 50

First-pass take

OptiBiotix is a pre-profitable biotech company with zero disclosed AI exposure, currently burning £1.8m annually against £870k revenue. While it has a strong balance sheet (no debt, £9m assets) and expanding partnerships (USA, India), execution risk is high and no valuation data provided. Fails AI-beneficiary and operating-leverage thresholds.

Flags

no-ai-exposurepre-profitablecash-burnno-valuation-dataexecution-dependentcustomer-concentration